NeoGenomics Inc (NEO)
15.30
+0.58
(+3.94%)
USD |
NASDAQ |
May 03, 16:00
15.30
0.00 (0.00%)
After-Hours: 20:00
NeoGenomics Price to Book Value: 2.116 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.116 |
| May 02, 2024 | 2.036 |
| May 01, 2024 | 1.931 |
| April 30, 2024 | 1.925 |
| April 29, 2024 | 2.105 |
| April 26, 2024 | 1.956 |
| April 25, 2024 | 1.911 |
| April 24, 2024 | 1.936 |
| April 23, 2024 | 1.954 |
| April 22, 2024 | 1.852 |
| April 19, 2024 | 1.867 |
| April 18, 2024 | 1.900 |
| April 17, 2024 | 1.888 |
| April 16, 2024 | 1.911 |
| April 15, 2024 | 1.898 |
| April 12, 2024 | 1.944 |
| April 11, 2024 | 2.004 |
| April 10, 2024 | 1.996 |
| April 09, 2024 | 2.100 |
| April 08, 2024 | 2.049 |
| April 05, 2024 | 2.059 |
| April 04, 2024 | 2.041 |
| April 03, 2024 | 2.052 |
| April 02, 2024 | 2.044 |
| April 01, 2024 | 2.124 |
| Date | Value |
|---|---|
| March 31, 2024 | |
| March 28, 2024 | 2.132 |
| March 27, 2024 | 2.061 |
| March 26, 2024 | 2.056 |
| March 25, 2024 | 2.001 |
| March 22, 2024 | 2.062 |
| March 21, 2024 | 2.093 |
| March 20, 2024 | 2.106 |
| March 19, 2024 | 1.995 |
| March 18, 2024 | 1.972 |
| March 15, 2024 | 1.991 |
| March 14, 2024 | 1.996 |
| March 13, 2024 | 2.097 |
| March 12, 2024 | 2.083 |
| March 11, 2024 | 2.159 |
| March 08, 2024 | 2.122 |
| March 07, 2024 | 2.163 |
| March 06, 2024 | 2.139 |
| March 05, 2024 | 2.136 |
| March 04, 2024 | 2.178 |
| March 01, 2024 | 2.164 |
| February 29, 2024 | 2.114 |
| February 28, 2024 | 2.109 |
| February 27, 2024 | 2.186 |
| February 26, 2024 | 2.205 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8059
Minimum
Oct 21 2022
10.07
Maximum
Feb 12 2021
4.060
Average
4.180
Median
Oct 22 2019
Price to Book Value Benchmarks
| Teladoc Health Inc | 0.9469 |
| Abbott Laboratories | 4.760 |
| Halozyme Therapeutics Inc | 60.39 |
| Verastem Inc | 4.808 |
| Ocugen Inc | 8.437 |
Price to Book Value Related Metrics
| PS Ratio | 3.151 |
| Price | 15.30 |
| Earnings Yield | -4.31% |
| Market Cap | 1.954B |